tiprankstipranks
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF
US Market
CRDF
Cardiff Oncology
RESEARCH TOOLSreports
Want to see CRDF full AI Analyst Report?

Cardiff Oncology (CRDF) Financial Statements

1,987 Followers

Cardiff Oncology Financial Overview

Cardiff Oncology's market cap is currently $116.90M. The company's EPS TTM is $; its P/E ratio is -4.09; Cardiff Oncology is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 593.00K$ 683.00K$ 488.00K$ 386.00K$ 359.00K
Gross Profit$ -311.00K$ 683.00K$ 488.00K$ 386.00K$ 359.00K
Operating Income$ -48.96M$ -48.65M$ -45.41M$ -39.90M$ -28.86M
EBITDA$ -44.97M$ -48.25M$ -45.01M$ -39.67M$ -28.40M
Net Income$ -45.88M$ -45.43M$ -41.44M$ -38.70M$ -28.29M
Balance Sheet
Cash & Short-Term Investments$ 58.30M$ 91.75M$ 74.82M$ 105.27M$ 140.82M
Total Assets$ 61.88M$ 97.19M$ 81.64M$ 116.19M$ 149.54M
Total Debt$ 832.00K$ 1.52M$ 2.15M$ 2.71M$ 3.12M
Net Debt$ -16.64M$ -49.95M$ -19.51M$ -13.63M$ -8.82M
Total Liabilities$ 16.50M$ 14.24M$ 11.90M$ 9.85M$ 9.13M
Stockholders' Equity$ 45.39M$ 82.95M$ 69.74M$ 106.34M$ 140.42M
Cash Flow
Free Cash Flow$ -37.97M$ -37.77M$ -31.47M$ -34.71M$ -23.25M
Operating Cash Flow$ -37.92M$ -37.69M$ -30.89M$ -33.82M$ -23.04M
Investing Cash Flow$ 1.34M$ 13.73M$ 36.20M$ 38.15M$ -131.45M
Financing Cash Flow$ 2.58M$ 53.78M$ 0.00$ 75.00K$ 35.45M
Currency in USD

Cardiff Oncology Earnings and Revenue History

Income Statement >

Cardiff Oncology Debt to Assets

Balance Sheet >

Cardiff Oncology Cash Flow

Cash Flow >

Cardiff Oncology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >